[{"data":1,"prerenderedAt":143},["ShallowReactive",2],{"drug-desonide":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":17,"formulations":21,"regimens":33,"contraindications":49,"warnings":59,"renal":67,"monitoring":68,"interactions":69,"review":70,"examples":73,"atc":74,"iran":76,"links":92,"populations":111,"usApproval":138},"desonide",1,{"fa":7,"en":8},"دزونید کرم ۰٫۰۵٪","Desonide cream 0.05%","dermatology",{"fa":11,"en":12},"کورتیکواستروئید موضعی ضعیف","Low-potency topical corticosteroid",[14],{"name":15,"market":16},"DesOwen","US",[18,19,20],"desowen","دزونید","کرم کورتون ضعیف",[22],{"id":23,"form":23,"route":24,"label":25,"concentration":26,"markets":28,"refs":29},"cream","topical","Desonide 0.05% cream (15, 60 g)",{"amount":5,"unit":27,"perUnit":27},"application",[16],[30],{"source":31,"section":32},"fda-desonide","How Supplied",[34],{"id":35,"disease":35,"label":36,"population":39,"type":40,"unit":41,"dose":42,"refs":46},"dermatitis",{"fa":37,"en":38},"درماتوزهای پاسخ‌دهنده به کورتون — ۲ تا ۴ بار در روز","Corticosteroid-responsive dermatoses — 2–4 times daily",{},"notCalculated","mg",{"reason":43},{"fa":44,"en":45},"لایه نازک ۲ تا ۴ بار در روز بسته به شدت؛ با کنترل قطع. اگر ظرف ۲ هفته بهتر نشد، تشخیص بازبینی. پانسمان بسته نه.","Thin film 2–4 times daily by severity; stop when controlled. Reassess if no improvement in 2 weeks. No occlusive dressings.",[47],{"source":31,"section":48},"Dosage and Administration",[50],{"id":51,"severity":52,"text":53,"refs":56},"hyper","block",{"fa":54,"en":55},"حساسیت به اجزای کرم.","Hypersensitivity to any component.",[57],{"source":31,"section":58},"Contraindications",[60],{"text":61,"refs":64},{"fa":62,"en":63},"جذب سیستمیک ممکن است محور HPA را سرکوب کند (به‌ویژه در کودک، سطح وسیع یا پانسمان بسته).","Systemic absorption can suppress the HPA axis (especially children, large areas or occlusion).",[65],{"source":31,"section":66},"Precautions",[],[],[],{"status":71,"reviewer":72,"date":72},"unverified",null,[],[75],"D07AB08",{"status":77,"forms":78,"refs":87},"registered",[79,83],{"code":80,"en":81,"fa":82},"52671","DESONIDE GEL 0.05 % 15Gr","ژل دسوناید ۰٫۰۵ درصد ۱۵ گرم",{"code":84,"en":85,"fa":86},"52670","DESONIDE OINTMENT 0.05 % 15Gr","پماد دسوناید ۰٫۰۵ درصد ۱۵ گرم",[88],{"source":89,"section":90,"url":91},"darooyab-generic","G-2088\u002FDesonide-Topical","https:\u002F\u002Fwww.darooyab.ir\u002FG-2088\u002FDesonide-Topical",[93,97,101,105,108],{"kind":94,"url":95,"label":96},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=214396","ANDA214396",{"kind":98,"url":99,"label":100},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=c3420815-e9d8-4c19-b601-b918b0aa1f84","FDA Desonide cream",{"kind":102,"url":103,"label":104},"medlineplus","https:\u002F\u002Fmedlineplus.gov\u002Fdruginfo\u002Fmeds\u002Fa605025.html","Desonide Topical",{"kind":106,"url":107,"label":75},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=D07AB08",{"kind":109,"url":91,"label":110},"darooyab","Desonide-Topical",{"pregnancy":112,"lactation":121,"pediatric":129},{"level":113,"text":114,"quote":117,"refs":118},"caution",{"fa":115,"en":116},"برچسب خطر مشخصی برای بارداری ذکر نکرده یا داده کافی ندارد؛ فقط در صورت لزوم و با نظر پزشک.","Label states no clear risk or has limited data; use only if needed, under medical advice.","Desonide cream USP, 0.05% should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.",[119],{"source":31,"section":120},"Precautions\u002FWarnings – Pregnancy",{"level":113,"text":122,"quote":125,"refs":126},{"fa":123,"en":124},"برچسب: در شیردهی با احتیاط؛ متن برچسب را ببینید.","Label: use with caution while breastfeeding; see the label text.","Because many drugs are excreted in human milk, caution should be exercised when desonide cream USP, 0.05% is administered to a nursing woman.",[127],{"source":31,"section":128},"Precautions\u002FWarnings – Nursing Mothers",{"level":130,"text":131,"quote":134,"refs":135},"not-established",{"fa":132,"en":133},"برچسب: ایمنی و اثربخشی در کودکان ثابت نشده است.","Label: safety and effectiveness in children have not been established.","- Safety and effectiveness in pediatric patients have not been established.",[136],{"source":31,"section":137},"Precautions\u002FWarnings – Pediatric Use",{"kind":139,"refs":140,"id":96},"ANDA",[141],{"source":31,"section":142},"SPL approval \u002F marketing category",1792111450946]